AZTA logo

Azenta, Inc. (AZTA)

Profile

Full Name

Azenta, Inc.

Ticker

NASDAQ: AZTA

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

February 2, 1995

Indexes

Not included

Website

https://www.azenta.com

Employees

3000

Key Details

Price

$30.46(-0.42%)

Market cap

Last Dividend

$0.10

TTM Dividend yield

-

Annual revenue

$656.32M(-1.32% YoY)

Annual EPS

-$3.09(-1304.55% YoY)

PE ratio

-

Next earnings date

Nov 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $30.46
    AZTA price is $30.46

    30-Day Relative Volume

    1.17
    AZTA 30-day relative volume is 1.17

    Price Performance

    Price Most recent change

    -0.42%
    AZTA price was down -0.42% on Sep 17, 2025

    Price YTD change

    -39.08%
    AZTA price is down -39.08% since January 1st

    Price 1-year change

    -37.94%
    AZTA price is down -37.94% year-on-year

    Price 3-year change

    -39.49%
    AZTA price is down -39.49% over the past 3 years

    Price Range

    Price All-time high

    $124.79
    AZTA price is currently -75.59% below its historical high of $124.79

    Price 3-year low

    $23.91
    AZTA price is currently +27.39% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.40B
    AZTA market capitalization is $1.40 billion

    Market cap 3-year change

    -63.03%
    AZTA market capitalization is down -63.03% over the past 3 years

    Market cap All-time high

    $9.23B
    AZTA market capitalization is currently -84.87% below its historical high of $9.23 billion

    Market cap sector rank

    76.68%
    AZTA market capitalization is higher than 76.68% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -6.29%
    AZTA shares outstanding is down -6.29% year-on-year

    Shares Outstanding 3-Year Change

    -38.9%
    AZTA shares outstanding is down -38.9% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.27
    AZTA beta is 1.27

    200-day SMA

    $36.60
    AZTA price is currently -16.79% below its 200-day simple moving average

    50-day SMA

    $31.07
    AZTA price is currently -1.96% below its 50-day simple moving average

    RSI

    50.98
    AZTA 14-day relative strength index is 50.98

    Volume

    1.17
    AZTA 30-day relative volume is 1.17

    ATR

    $1.30
    AZTA average true range is $1.30

    10-day Historical Volatility

    49.43%
    AZTA 10-day historical volatility is 49.43%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.10
    AZTA last dividend was $0.10 per share, with an ex-dividend date of December 2, 2021

    Next Dividend

    -
    AZTA next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    AZTA annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    AZTA annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    AZTA annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    AZTA annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    AZTA annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    AZTA annual dividend yield is unknown

    Other

    Payout ratio

    0.00%
    AZTA annual payout ratio is 0.00%

    Dividends paid

    $0.00
    AZTA annual dividends paid is $0.00

    Free cash flow

    $12.90M
    AZTA annual free cash flow is $12.90 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $656.32M
    AZTA annual revenue is $656.32 million

    Revenue Analysts estimate

    $592.24M
    AZTA annual revenue is currently +10.82% higher than the consensus analysts' forecast

    Revenue 1-year change

    -1.32%
    AZTA annual revenue is down -1.32% year-on-year

    Revenue Sector rank

    82.86%
    AZTA annual revenue is higher than 82.86% of companies in Healthcare sector

    EPS

    EPS

    -$3.09
    AZTA annual earnings per share is -$3.09

    EPS Analysts estimate

    $0.51
    AZTA annual earnings per share is currently -703.87% lower than the consensus analysts' forecast

    EPS 1-year change

    -1304.55%
    AZTA annual earnings per share is down -1304.55% year-on-year

    EPS Sector rank

    27.88%
    AZTA annual earnings per share is higher than 27.88% of companies in Healthcare sector

    Profit

    Gross profit

    $263.37M
    AZTA annual gross profit is $263.37 million

    Gross margin

    40.13%
    AZTA annual gross profit margin is 40.13%

    Operating profit

    -$72.89M
    AZTA annual operating income is -$72.89 million

    Operating margin

    -11.11%
    AZTA annual operating profit margin is -11.11%

    Net income

    -$164.17M
    AZTA annual net profit is -$164.17 million

    Net margin

    -25.01%
    AZTA annual net profit margin is -25.01%

    Expenses

    Total expenses

    $729.22M
    AZTA annual total expenses is $729.22 million

    Operating expenses

    $336.26M
    AZTA annual total operating expenses is $336.26 million

    Cost of goods sold

    $392.96M
    AZTA annual cost of goods sold is $392.96 million

    Selling, general & administrative expenses

    $302.74M
    AZTA annual SGA is $302.74 million

    Depreciation and amortization

    $90.74M
    AZTA annual depreciation & amortization is $90.74 million

    Interest expense

    $0.00
    AZTA annual interest expense is $0.00

    Income tax

    -$3.15M
    AZTA annual income tax is -$3.15 million

    EBIT & EBITDA

    EBIT

    -$72.89M
    AZTA annual earnings before interest & taxes is -$72.89 million

    EBITDA

    -$72.89M
    AZTA annual EBITDA is -$72.89 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $2.10B
    AZTA annual total assets is $2.10 billion

    Non current assets

    $1.27B
    AZTA annual long term assets is $1.27 billion

    Current assets

    $832.81M
    AZTA annual total current assets is $832.81 million

    Cash and cash equivalents

    $310.93M
    AZTA annual cash & cash equivalents is $310.93 million

    Accounts receivable

    $201.91M
    AZTA annual accounts receivable is $201.91 million

    Inventory

    $115.26M
    AZTA annual inventory is $115.26 million

    Liabilities

    Total liabilities

    $331.07M
    AZTA annual total liabilities is $331.07 million

    Long term liabilities

    $126.23M
    AZTA annual total long term liabilities is $126.23 million

    Current liabilities

    $204.84M
    AZTA annual total current liabilities is $204.84 million

    Accounts payable

    $44.43M
    AZTA annual accounts payable is $44.43 million

    Debt

    Total debt

    $70.68M
    AZTA annual total debt is $70.68 million

    Total debt 1-year change

    -1.8%
    AZTA annual total debt is down -1.8% year-on-year

    Long term debt

    $60.13M
    AZTA annual long term debt is $60.13 million

    Short term debt

    $10.55M
    AZTA annual short term debt is $10.55 million

    Equity & Capital

    Shareholders equity

    $1.77B
    AZTA annual stockholders equity is $1.77 billion

    Book value

    $1.77B
    AZTA annual book value is $1.77 billion

    Retained earnings

    $1.48B
    AZTA annual retained earnings is $1.48 billion

    Working capital

    $627.97M
    AZTA annual working capital is $627.97 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $50.29M
    AZTA annual cash flow from operations is $50.29 million

    Cash from operations 1-year change

    +602.56%
    AZTA annual cash flow from operations is up +602.56% year-on-year

    Cash from investing

    $224.74M
    AZTA annual cash flow from investing activities is $224.74 million

    Cash from investing 1-year change

    -47.9%
    AZTA annual cash flow from investing activities is down -47.9% year-on-year

    Cash from financing

    -$659.21M
    AZTA annual cash flow from financing activities is -$659.21 million

    Cash from financing 1-year change

    +21.57%
    AZTA annual cash flow from financing activities is up +21.57% year-on-year

    CAPEX

    CAPEX

    $37.39M
    AZTA annual capital expenditures is $37.39 million

    CAPEX 1-year change

    -5.18%
    AZTA annual capital expenditures is down -5.18% year-on-year

    Free Cash Flow

    Free cash flow

    $12.90M
    AZTA annual free cash flow is $12.90 million

    Free cash flow 1-year change

    +139.96%
    AZTA annual free cash flow is up +139.96% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    40.13%
    AZTA annual gross profit margin is 40.13%

    Operating margin

    -11.11%
    AZTA annual operating profit margin is -11.11%

    Net margin

    -25.01%
    AZTA annual net profit margin is -25.01%

    ROA & ROE

    ROA

    -6.59%
    AZTA annual return on assets is -6.59%

    ROE

    -7.63%
    AZTA annual return on equity is -7.63%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AZTA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AZTA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.83
    AZTA price to book ratio is 0.83

    PB ratio Sector rank

    31.2%
    AZTA price to book ratio is higher than 31.2% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.31
    AZTA price to sales ratio is 2.31

    PS ratio Sector rank

    39.36%
    AZTA price to sales ratio is higher than 39.36% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.13B
    AZTA enterprise value is $1.13 billion

    Enterprise value Sector rank

    74.7%
    AZTA enterprise value is higher than 74.7% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    31.19
    AZTA EV/EBITDA is 31.19

    EV/EBITDA Sector rank

    94.08%
    AZTA EV/EBITDA is higher than 94.08% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.07
    AZTA annual current ratio is 4.07

    Quick ratio

    3.50
    AZTA annual quick ratio is 3.50

    Leverage

    Debt to equity

    0.00
    AZTA annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    AZTA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    6
    AZTA piotroski f-score is 6

    Altman Z-Score

    4.07
    AZTA altman z-score is 4.07

    Analyst ratings

    Recent major analysts updates

    Aug 6, 25 Raymond James
    Outperform
    Aug 5, 25 Evercore ISI Group
    In-Line
    Jul 8, 25 Evercore ISI Group
    In-Line
    May 7, 25 Needham
    Buy
    Feb 6, 25 Needham
    Buy
    Feb 6, 25 Evercore ISI Group
    In-Line
    Jan 2, 25 Stephens & Co.
    Overweight
    Dec 18, 24 Stephens & Co.
    Overweight
    Nov 13, 24 Needham
    Buy
    Oct 1, 24 Evercore ISI Group
    In-Line

    Institutional Ownership

    Screeners with AZTA included

    US stocks
    High Piotroski score stocks
    Stocks with high beta
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for Azenta, Inc.?
    • Does Azenta, Inc. pay dividends?
    • What sector is Azenta, Inc. in?
    • What industry is Azenta, Inc. in?
    • What country is Azenta, Inc. based in?
    • When did Azenta, Inc. go public?
    • Is Azenta, Inc. in the S&P 500?
    • Is Azenta, Inc. in the NASDAQ 100?
    • Is Azenta, Inc. in the Dow Jones?
    • When was Azenta, Inc.'s last earnings report?
    • When does Azenta, Inc. report earnings?

    What is the ticker symbol for Azenta, Inc.?

    The ticker symbol for Azenta, Inc. is NASDAQ:AZTA

    Does Azenta, Inc. pay dividends?

    No, Azenta, Inc. does not pay dividends

    What sector is Azenta, Inc. in?

    Azenta, Inc. is in the Healthcare sector

    What industry is Azenta, Inc. in?

    Azenta, Inc. is in the Medical Instruments & Supplies industry

    What country is Azenta, Inc. based in?

    Azenta, Inc. is headquartered in United States

    When did Azenta, Inc. go public?

    Azenta, Inc.'s initial public offering (IPO) was on February 2, 1995

    Is Azenta, Inc. in the S&P 500?

    No, Azenta, Inc. is not included in the S&P 500 index

    Is Azenta, Inc. in the NASDAQ 100?

    No, Azenta, Inc. is not included in the NASDAQ 100 index

    Is Azenta, Inc. in the Dow Jones?

    No, Azenta, Inc. is not included in the Dow Jones index

    When was Azenta, Inc.'s last earnings report?

    Azenta, Inc.'s most recent earnings report was on August 5, 2025

    When does Azenta, Inc. report earnings?

    The next expected earnings date for Azenta, Inc. is November 11, 2025
    On this page